Novo Nordisk's Pill, Orsted Winded, Pets At Home Up
On This episode of Stock Movers: - Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. - Orsted said it’s considering “all options” including legal action as it weighs how to respond to a US decision to suspend leases for five offshore wind farms, according to a statement late Monday. - Pets at Home Group named James Bailey, the former managing director of upmarket grocer Waitrose, as its new chief executive officer to lead a reboot of the struggling…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.